Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Fund Raise

Kataria Industries Fund Raise of ₹63.6 Cr

Kataria Industries approved a preferential issue of 60 lakh equity shares for Rs.63.60 Crore, alongside a dividend of Rs.0.50 per share and board appointments.

Key figures
Value₹63.60 Cr
Source

NSE filing, NSE: KATARIA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Kataria Industries Ltd: key numbers

Share price
₹129.00
Market cap
₹338.9 Cr
Revenue (annual)
₹331.0 Cr
Net profit (annual)
₹12.12 Cr
P/E (TTM)
28.0×Sector 16.5×
Promoter holding
61.45%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Kataria Industries Ltd

All →

Other fund raise announcements

All →
20:28 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value
₹72.00 Cr
19:27 IST NSE
Fund RaiseFlywings Simulator Training Centre Ltd FWSTC

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value
₹68.20 Cr
16:20 IST BSE
Fund RaiseKanel Industries Ltd KANELOIL

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value
₹16.99 Cr
Execution
Rights issue opens 23 November 2026 and closes 30 November 2026
15:05 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.